Grant: Discovery Grants Program - Individual
Simon Fraser University
$30,000.00
Folding pathways for membrane-binding amphipathic helices
EF 2011-12
Résumé
Many neuropathologies are associated with protein mis-folding into fibrils called ""beta-amyloid"", including Parkinson's Disease. A mis-folded form of the protein alpha-synuclein accumulates in certain neurons in the brains of people with PD, and causes cell death. When alpha-synuclein folds ""properly"" it coils into a helix and attaches to intracellular membrane vesicles that store neurotransmitters. Its productive function in regulating the fusion of these vesicles with the cell membrane and neurotransmitter release into the synapse is predicated upon this helical folding. If scientists could find a way to promote the native helical folding of alpha-synuclein and discourage the mis-folding into pathogenic proto-fibrils, then the neuronal cells might be rescued from cell death, and Parkinson's Disease symptoms might be reversed. We have discovered during our studies of an important metabolic enzyme, cytidylyltransferase (CCT), that alpha-synuclein resembles the tail portion of CCT in structure and function. But CCT, which is an enzyme that controls the synthesis of membrane phospholipids, does not mis-fold in cells. CCT, but not alpha-synuclein, contains a globular head domain that could prevent mis-folding of its own tail. Our proposal has three aims: 1). To characterize in parallel the structure and membrane-binding properties of synuclein and the CCT tail. 2). To determine if the CCT tail mis-folds into amyloidogenic particles or fibrils when it is missing a connection to its head domain. 3). To assess whether the CCT tail domain (if it does NOT mis-fold) can serve as a chaperone to prevent mis-folding of alpha-synuclein, or alternatively to assess whether a chimeric protein composed of the CCT head domain linked to alpha-synuclein - when added to alpha-synuclein can prevent misfolding. Our research will provide basic information about the causes of protein mis-folding.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
107577-2011
Name nom
Cornell, Rosemary
Department département
Molecular Biology and Biochemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
30000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
5
Application title
Folding pathways for membrane-binding amphipathic helices
Keyword
NSERC
Application summary
Many neuropathologies are associated with protein mis-folding into fibrils called ""beta-amyloid"", including Parkinson's Disease. A mis-folded form of the protein alpha-synuclein accumulates in certain neurons in the brains of people with PD, and causes cell death. When alpha-synuclein folds ""properly"" it coils into a helix and attaches to intracellular membrane vesicles that store neurotransmitters. Its productive function in regulating the fusion of these vesicles with the cell membrane and neurotransmitter release into the synapse is predicated upon this helical folding. If scientists could find a way to promote the native helical folding of alpha-synuclein and discourage the mis-folding into pathogenic proto-fibrils, then the neuronal cells might be rescued from cell death, and Parkinson's Disease symptoms might be reversed. We have discovered during our studies of an important metabolic enzyme, cytidylyltransferase (CCT), that alpha-synuclein resembles the tail portion of CCT in structure and function. But CCT, which is an enzyme that controls the synthesis of membrane phospholipids, does not mis-fold in cells. CCT, but not alpha-synuclein, contains a globular head domain that could prevent mis-folding of its own tail. Our proposal has three aims: 1). To characterize in parallel the structure and membrane-binding properties of synuclein and the CCT tail. 2). To determine if the CCT tail mis-folds into amyloidogenic particles or fibrils when it is missing a connection to its head domain. 3). To assess whether the CCT tail domain (if it does NOT mis-fold) can serve as a chaperone to prevent mis-folding of alpha-synuclein, or alternatively to assess whether a chimeric protein composed of the CCT head domain linked to alpha-synuclein - when added to alpha-synuclein can prevent misfolding. Our research will provide basic information about the causes of protein mis-folding.